Page last updated: 2024-08-23

pregnanolone and HIV Coinfection

pregnanolone has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Akins, NS; Le, HV; Li, J; Mahdi, F; Moss, E; Paris, JJ; Qrareya, AN; Salahuddin, MF1
Mahdi, F; Paris, JJ; Salahuddin, MF; Sulochana, SP1

Reviews

1 review(s) available for pregnanolone and HIV Coinfection

ArticleYear
Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapy.
    Journal of neuroendocrinology, 2022, Volume: 34, Issue:2

    Topics: Central Nervous System; HIV Infections; HIV-1; Humans; Neurosecretory Systems; Pregnanolone

2022

Other Studies

1 other study(ies) available for pregnanolone and HIV Coinfection

ArticleYear
HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone's Psychomotor Effects in Female Mice.
    Viruses, 2021, 04-30, Volume: 13, Issue:5

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Estrous Cycle; Female; HIV Infections; HIV-1; Humans; Hypothalamo-Hypophyseal System; Mice; Motor Activity; Neurosecretory Systems; Oxycodone; Pituitary-Adrenal System; Pregnanolone; Psychomotor Performance; Steroids; tat Gene Products, Human Immunodeficiency Virus

2021